Antimicrobial Agents — MCQs

Antimicrobial Agents Indian Medical PG Practice Questions and MCQs

Question 21: Regarding the lipid or liposomal formulations of amphotericin B, which of the following statements is accurate?

A. They are less expensive to use than conventional amphotericin B.
B. They are more effective in fungal infections than conventional preparations because they increase tissue uptake of amphotericin B.
C. They may decrease the nephrotoxicity of amphotericin B. (Correct Answer)
D. They have a wider spectrum of antifungal activity than conventional formulations of amphotericin B.

Explanation: ### Explanation **1. Why the Correct Answer is Right (Option C):** Conventional Amphotericin B Deoxycholate is notorious for its dose-limiting **nephrotoxicity**, caused by non-specific binding to cholesterol in human renal tubular membranes. Lipid formulations (Liposomal Amphotericin B, ABCD, and ABLC) use lipid vehicles as "carriers." These lipids have a higher affinity for the drug than human cell membranes. This allows the drug to remain sequestered within the lipid vehicle while in the systemic circulation, reducing exposure to the renal tubules and significantly **decreasing nephrotoxicity**. The drug is primarily released when it encounters fungal lipases at the site of infection. **2. Why the Other Options are Incorrect:** * **Option A:** Lipid formulations are significantly **more expensive** than conventional preparations due to complex manufacturing processes. This is their primary clinical drawback. * **Option B:** They are **not more effective** than conventional amphotericin B. Their efficacy (spectrum and potency) remains comparable; their main advantage is a superior safety profile, allowing for higher dosing if necessary. * **Option D:** The **antifungal spectrum remains the same**. The active moiety is still Amphotericin B; only the delivery vehicle changes. It remains the drug of choice for most systemic mycoses (Mucormycosis, Cryptococcosis). **3. High-Yield Clinical Pearls for NEET-PG:** * **Mechanism of Action:** Binds to **ergosterol** in the fungal cell membrane, creating pores that lead to ion leakage (K+) and cell death. * **Infusion-Related Toxicity:** "Shake and Bake" (fever, chills, rigors) is common with conventional forms; lipid formulations reduce but do not entirely eliminate these reactions. * **Electrolyte Imbalance:** Watch for **Hypokalemia** and **Hypomagnesemia** due to renal tubular damage. * **Liposomal Formulations:** AmBisome (Liposomal), Abelcet (ABLC), and Amphotec (ABCD). Among these, the Liposomal form (AmBisome) generally has the best safety profile.

Question 22: Which fluoroquinolone has the least oral bioavailability?

A. Norfloxacin (Correct Answer)
B. Ofloxacin
C. Ciprofloxacin
D. Levofloxacin

Explanation: **Explanation:** The correct answer is **Norfloxacin (Option A)**. **1. Why Norfloxacin is correct:** Bioavailability refers to the fraction of an administered drug that reaches the systemic circulation in an unchanged form. Among the fluoroquinolones, **Norfloxacin** has the poorest oral absorption, with a bioavailability of only **30–50%**. Because of this low systemic concentration, it is not used for respiratory or systemic infections. Instead, its use is primarily restricted to **Urinary Tract Infections (UTIs)** and infectious diarrhea, where high concentrations in the urine and gut are beneficial. **2. Why the other options are incorrect:** * **Ofloxacin (Option B):** Has excellent oral bioavailability, typically exceeding **95%**. It is well-absorbed and reaches high systemic concentrations. * **Ciprofloxacin (Option C):** Has a moderate to good bioavailability of approximately **70%**. While lower than Levofloxacin, it is significantly higher than Norfloxacin. * **Levofloxacin (Option D):** Known for its "near-perfect" bioavailability of approximately **99%**. This allows for a 1:1 transition between oral and intravenous dosing (sequential therapy). **3. NEET-PG High-Yield Pearls:** * **Bioavailability Trend:** Levofloxacin (99%) > Ofloxacin (95%) > Ciprofloxacin (70%) > Norfloxacin (35%). * **Food/Cation Interaction:** All fluoroquinolones exhibit reduced absorption when taken with antacids (Al, Mg), iron, or calcium due to **chelation**. * **Excretion:** Most fluoroquinolones are renally excreted; however, **Moxifloxacin** is primarily excreted via the liver and does not require dose adjustment in renal failure (but cannot be used for UTIs). * **Mechanism:** They inhibit **DNA Gyrase** (Gram-negative) and **Topoisomerase IV** (Gram-positive).

Question 23: Why are aminoglycosides administered in a single daily dose instead of thrice daily?

A. Very long half-life
B. Time-dependent killing
C. Increased binding to plasma proteins
D. Long post-antibiotic effect (Correct Answer)

Explanation: ### Explanation Aminoglycosides (e.g., Gentamicin, Amikacin) are traditionally administered as a **Single Daily Dose (SDD)** or "Once-daily dosing" [1] due to two primary pharmacological properties: **Concentration-dependent killing** and a **Long Post-Antibiotic Effect (PAE)** [2]. **1. Why Option D is Correct:** The **Post-Antibiotic Effect (PAE)** refers to the continued suppression of bacterial growth even after the serum concentration of the antibiotic falls below the Minimum Inhibitory Concentration (MIC) [2]. Aminoglycosides have a significant PAE (often 3–5 hours) [2]. By giving a large single dose, we achieve a high peak concentration ($C_{max}$), which maximizes the killing rate and extends the PAE, allowing the drug to remain effective even when blood levels are low [2]. This also reduces the risk of "adaptive resistance." **2. Why Other Options are Incorrect:** * **Option A:** Aminoglycosides actually have a **short half-life** (approx. 2–3 hours in patients with normal renal function). They do not stay in the blood for long, which is why the PAE is necessary for once-daily dosing. * **Option B:** Aminoglycosides exhibit **Concentration-dependent killing** (the higher the peak, the better the kill). **Time-dependent killing** is a characteristic of Beta-lactams (Penicillins/Cephalosporins), which require frequent dosing to keep levels above MIC. * **Option C:** Aminoglycosides have **very low plasma protein binding** (<10%). They are highly polar, water-soluble molecules. **Clinical Pearls for NEET-PG:** * **Toxicity Benefit:** SDD reduces the risk of **Nephrotoxicity** and **Ototoxicity** [3]. These toxicities are "saturable"; a single high peak followed by a long "washout" period prevents the drug from accumulating in the renal cortex and inner ear hair cells [3]. * **Monitoring:** For SDD, we monitor the **trough level** (just before the next dose) to ensure it is low enough to prevent toxicity. * **Target Ratio:** For maximum efficacy, the $C_{max}/MIC$ ratio should be **8:1 to 10:1**.

Question 24: What is the drug of choice for hepatitis B?

A. Beta interferon
B. Sofosbuvir
C. Simeprevir
D. Tenofovir (Correct Answer)

Explanation: **Explanation:** The management of Chronic Hepatitis B (CHB) focuses on the long-term suppression of HBV DNA replication to prevent cirrhosis and hepatocellular carcinoma. **Why Tenofovir is the Correct Answer:** **Tenofovir** (specifically Tenofovir Disoproxil Fumarate or Tenofovir Alafenamide) and **Entecavir** [2] are the first-line oral antiviral agents (Nucleoside/Nucleotide Analogue Reverse Transcriptase Inhibitors) for Hepatitis B. Tenofovir is preferred due to its **high genetic barrier to resistance**, potent antiviral efficacy, and favorable safety profile [3]. Unlike older drugs like Lamivudine, resistance to Tenofovir is clinically negligible even after years of therapy [3]. **Analysis of Incorrect Options:** * **A. Beta interferon:** While Peginterferon **alpha**-2a is a treatment option for HBV [1], Beta interferon is primarily used in the management of Multiple Sclerosis. * **B. Sofosbuvir:** This is a NS5B polymerase inhibitor used exclusively for **Hepatitis C** (HCV) [3]. It has no clinical role in treating HBV. * **C. Simeprevir:** This is a second-generation protease inhibitor used in the treatment of **Hepatitis C** (HCV) genotype 1. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice (DOC):** Tenofovir or Entecavir are the preferred oral agents. * **Pregnancy:** Tenofovir is the DOC for treating HBV in pregnant women to prevent vertical transmission (Category B). * **HIV Co-infection:** Tenofovir is a component of ART and is ideal for patients co-infected with HBV and HIV. * **Side Effects:** Monitor for nephrotoxicity and decreased bone mineral density with Tenofovir Disoproxil Fumarate (TDF). Tenofovir Alafenamide (TAF) has better bone and renal safety.

Question 25: What is the drug of choice for Mycoplasma pneumoniae?

A. Penicillin
B. Tetracycline
C. Cefuroxime
D. Erythromycin (Correct Answer)

Explanation: **Explanation:** The drug of choice for *Mycoplasma pneumoniae* is **Erythromycin** (or other Macrolides like Azithromycin and Clarithromycin). **1. Why Erythromycin is correct:** *Mycoplasma pneumoniae* is an "atypical" bacterium that **lacks a peptidoglycan cell wall**. Macrolides work by inhibiting protein synthesis (binding to the 50S ribosomal subunit) rather than targeting the cell wall. Therefore, they are highly effective against this organism. In clinical practice, Azithromycin is often preferred due to better tolerability, but Erythromycin remains the classic textbook answer and drug of choice for NEET-PG purposes. **2. Why the other options are incorrect:** * **Penicillin (A) and Cefuroxime (C):** These are Beta-lactam antibiotics. Their mechanism of action involves inhibiting cell wall synthesis. Since *Mycoplasma* lacks a cell wall, it is **innately resistant** to all Beta-lactams (Penicillins, Cephalosporins, and Carbapenems). * **Tetracycline (B):** While Tetracyclines (like Doxycycline) are effective against *Mycoplasma* and are considered second-line or alternative treatments, they are generally not the first choice in children or pregnant women due to side effects on teeth and bones. Macrolides maintain a superior safety profile and efficacy record for this specific indication. **High-Yield Clinical Pearls for NEET-PG:** * **Atypical Pneumonia:** *Mycoplasma* is the most common cause of "Walking Pneumonia," characterized by a dissociated clinical picture (severe X-ray findings but mild physical symptoms). * **Diagnosis:** Cold agglutinin test (IgM antibodies) is a classic bedside screening test. * **Side Effects:** Remember the mnemonic **MACRO** for Erythromycin: **M**otility (GI upset), **A**rrhythmia (prolonged QT), **C**holestatic hepatitis, **R**ash, and **O**totoxicity.

Question 26: Which of the following drugs does NOT act against HIV-2?

A. Ritonavir
B. Tenofovir
C. Efavirenz (Correct Answer)
D. Zalcitabine

Explanation: **Explanation:** The correct answer is **Efavirenz**. The fundamental concept here is the structural difference between the Reverse Transcriptase (RT) enzymes of HIV-1 and HIV-2. **Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)**, such as Efavirenz, Nevirapine, and Delavirdine, bind to a specific hydrophobic pocket on the HIV-1 RT enzyme. HIV-2 lacks this specific binding site, making it **intrinsically resistant** to all first-generation NNRTIs. **Analysis of Options:** * **Efavirenz (Option C):** As an NNRTI, it is ineffective against HIV-2. This is a high-yield distinction because HIV-2 infections must be treated with regimens that exclude NNRTIs. * **Ritonavir (Option A):** This is a Protease Inhibitor (PI). Most PIs are active against both HIV-1 and HIV-2, though HIV-2 may show reduced sensitivity to some (e.g., Amprenavir). * **Tenofovir (Option B) & Zalcitabine (Option D):** These are Nucleoside/Nucleotide Reverse Transcriptase Inhibitors (NRTIs). NRTIs act as competitive inhibitors and chain terminators for the RT enzyme in both HIV-1 and HIV-2. **NEET-PG High-Yield Pearls:** 1. **HIV-2 Resistance Profile:** Naturally resistant to **NNRTIs** and **Enfuvirtide** (Fusion Inhibitor). 2. **Drugs of Choice for HIV-2:** Usually includes a backbone of two NRTIs plus an Integrase Inhibitor (INSTI) or a boosted Protease Inhibitor (e.g., Lopinavir/r or Darunavir/r). 3. **Monitoring:** HIV-2 cannot be monitored using standard HIV-1 viral load assays; specific HIV-2 DNA/RNA PCR tests are required.

Question 27: Fluconazole is more effective than itraconazole in which of the following systemic fungal diseases?

A. Pulmonary histoplasmosis
B. Cryptococcal meningitis (Correct Answer)
C. Non-meningeal blastomycosis
D. Disseminated sporotrichosis

Explanation: The primary reason **Fluconazole** is more effective than Itraconazole in **Cryptococcal meningitis** is its superior pharmacokinetic profile regarding the Central Nervous System (CNS) [2]. 1. **Why Option B is correct:** Fluconazole is a small, water-soluble molecule with low protein binding, allowing it to achieve **excellent cerebrospinal fluid (CSF) penetration** (reaching 60–90% of serum levels) [1], [2]. Itraconazole, conversely, is highly lipophilic, protein-bound, and has negligible CSF penetration [2]. While Amphotericin B + Flucytosine is the induction therapy of choice [3], Fluconazole is the drug of choice for **maintenance/suppression therapy** in Cryptococcal meningitis. 2. **Why other options are incorrect:** * **Histoplasmosis (A), Blastomycosis (C), and Sporotrichosis (D):** These are caused by dimorphic fungi. **Itraconazole** is the preferred agent for mild-to-moderate infections of this type because it has a broader spectrum of activity and higher intrinsic potency against these specific pathogens compared to Fluconazole [4]. Fluconazole is generally considered a second-line or alternative agent for these conditions due to lower efficacy. **High-Yield Clinical Pearls for NEET-PG:** * **Fluconazole Spectrum:** Excellent for *Candida albicans* and *Cryptococcus*, but has **no activity** against *Aspergillus* or Mucormycosis. * **Resistance:** *Candida krusei* is intrinsically resistant to Fluconazole; *Candida glabrata* shows dose-dependent resistance. * **Itraconazole:** Drug of choice for Histoplasmosis, Blastomycosis, Sporotrichosis, and Chromoblastomycosis. It requires an acidic gastric environment for optimal absorption. * **Side Effect:** All azoles inhibit CYP450 enzymes, but Fluconazole has the least effect on hepatic microsomal enzymes compared to Ketoconazole or Itraconazole.

Question 28: All of the following are therapeutic uses of Penicillin G, except?

A. Bacterial meningitis
B. Rickettsial infection (Correct Answer)
C. Syphilis
D. Anthrax

Explanation: **Explanation:** **Penicillin G (Benzylpenicillin)** is a narrow-spectrum antibiotic that acts by inhibiting bacterial cell wall synthesis. It is primarily effective against Gram-positive cocci, Gram-positive bacilli, and some Gram-negative cocci. **Why Rickettsial infection is the correct answer:** Rickettsiae (the causative agents of Rocky Mountain spotted fever and Typhus) are **obligate intracellular bacteria**. Penicillin G is ineffective against them because it has poor intracellular penetration and Rickettsiae do not have a typical peptidoglycan cell wall structure sensitive to beta-lactams. The drugs of choice for Rickettsial infections are **Tetracyclines (Doxycycline)** or Chloramphenicol. **Analysis of incorrect options:** * **Bacterial Meningitis:** Penicillin G remains a first-line treatment for meningitis caused by *Neisseria meningitidis* and *Streptococcus pneumoniae* (if sensitive), as it achieves therapeutic concentrations in the CSF when the meninges are inflamed. * **Syphilis:** Penicillin G is the **gold standard** treatment for all stages of syphilis (*Treponema pallidum*). Long-acting Benzathine Penicillin G is specifically used for primary, secondary, and latent syphilis. * **Anthrax:** *Bacillus anthracis* is highly susceptible to Penicillin G. While Ciprofloxacin or Doxycycline are often used initially due to potential bioterrorism resistance, Penicillin G is a classic therapeutic option for sensitive strains. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice (DOC):** Penicillin G is the DOC for Syphilis, Gas gangrene (*C. perfringens*), Rat-bite fever, and Actinomycosis. * **Route:** Penicillin G is acid-labile and destroyed by gastric acid; hence, it must be given parenterally (IV/IM). * **Jarisch-Herxheimer Reaction:** A classic side effect seen during the treatment of Syphilis with Penicillin due to the release of endotoxins from dying spirochetes.

Question 29: All of the following drugs are used in the treatment of Giardiasis except?

A. Nitazoxanide
B. Metronidazole
C. Tinidazole
D. Diloxanide furoate (Correct Answer)

Explanation: **Explanation:** The treatment of Giardiasis focuses on drugs that are effective against the flagellated protozoan *Giardia lamblia*. **Why Diloxanide furoate is the correct answer:** Diloxanide furoate is a **luminal amoebicide**. It is highly effective against the trophozoites and cysts of *Entamoeba histolytica* residing in the intestinal lumen, but it has **no clinical activity against *Giardia lamblia***. It is primarily used as the drug of choice for asymptomatic cyst passers in amoebiasis or to eradicate the luminal survivors after treatment of invasive amoebiasis with tissue amoebicides. **Analysis of incorrect options:** * **Metronidazole:** This is the traditional drug of choice for Giardiasis. It is a nitroimidazole that causes DNA strand breakage in anaerobic organisms. * **Tinidazole:** A second-generation nitroimidazole with a longer half-life than metronidazole. It is often preferred because it can be administered as a **single dose**, leading to better patient compliance. * **Nitazoxanide:** A broad-spectrum thiazolide anti-infective agent approved for the treatment of diarrhea caused by *Giardia lamblia* and *Cryptosporidium parvum*, especially in children (available as a suspension). **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice (DOC):** While Metronidazole is standard, **Tinidazole (single dose)** is often considered superior due to efficacy and compliance. * **Pregnancy:** Paromomycin (a luminal aminoglycoside) is often preferred if treatment is mandatory during the first trimester, though many experts delay treatment until after delivery. * **Mechanism of Nitazoxanide:** It inhibits the pyruvate:ferredoxin oxidoreductase (PFOR) enzyme pathway. * **Other alternatives:** Albendazole and Furazolidone are also effective against Giardia.

Question 30: What is the recommended dose of Dapsone?

A. 1-2 mg/kg (Correct Answer)
B. 5 mg/kg
C. 10 mg/kg
D. 20 mg/kg

Explanation: **Explanation:** **Dapsone (Diaminodiphenyl sulfone)** is the bacteriostatic mainstay in the treatment of Leprosy and various dermatological conditions. The standard therapeutic dose for an adult is **100 mg daily**, which translates to approximately **1–2 mg/kg** body weight. 1. **Why 1-2 mg/kg is correct:** This dosage range provides optimal plasma concentrations to inhibit folic acid synthesis in *Mycobacterium leprae* while maintaining a manageable safety profile. In the WHO Multi-Drug Therapy (MDT) for Leprosy, the adult dose is fixed at 100 mg/day, and the pediatric dose is approximately 2 mg/kg/day. 2. **Why other options are incorrect:** * **5 mg/kg and 10 mg/kg:** These doses are excessively high for routine use. Dapsone exhibits dose-dependent toxicity; higher doses significantly increase the risk of severe hematological adverse effects. * **20 mg/kg:** This is a toxic dose. Dapsone levels in this range would lead to life-threatening methemoglobinemia and fulminant hemolytic anemia. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism of Action:** Competitive inhibitor of dihydropteroate synthase (DHPS), similar to sulfonamides. * **Adverse Effects:** * **Hemolysis:** Most common side effect; occurs especially in **G6PD deficient** patients. * **Methemoglobinemia:** Presents with cyanosis; treated with Methylene Blue. * **Dapsone Syndrome:** A severe hypersensitivity reaction (fever, exfoliative dermatitis, hepatitis, and lymphadenopathy) occurring 4–6 weeks after starting therapy. * **Drug of Choice:** Dapsone is the drug of choice for **Dermatitis Herpetiformis**. * **Pharmacokinetics:** It undergoes enterohepatic circulation, leading to a long half-life (approx. 24–30 hours).

Practice by Chapter

Beta-Lactam Antibiotics

Practice Questions

Aminoglycosides

Practice Questions

Macrolides and Ketolides

Practice Questions

Tetracyclines

Practice Questions

Quinolones

Practice Questions

Sulfonamides and Trimethoprim

Practice Questions

Antimycobacterial Drugs

Practice Questions

Antifungal Agents

Practice Questions

Antiviral Drugs

Practice Questions

Antiparasitic Agents

Practice Questions

Principles of Antimicrobial Selection

Practice Questions

Antimicrobial Resistance

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free